Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s interface revision/version indicator has been updated from “v3.5.2” to “v3.5.3,” reflecting a site release without changing the study record details shown.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Release notes updated to add Revision: v3.5.2 and remove Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:16:11.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T22:34:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.3 and removes the previous entry v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T19:57:45.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A new site revision entry (v3.4.2) was added. The previous funding-lapse notice (v3.4.1) was removed.
    Difference
    0.7%
    Check dated 2026-02-11T04:40:09.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and operating status, and updated the record history to Revision: v3.4.1. The previous Revision: v3.4.0 entry was removed.
    Difference
    0.8%
    Check dated 2026-02-04T03:23:12.000Z thumbnail image

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.